aldosterone has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuda, M | 1 |
| Hirata, A | 1 |
| Tokunaga, S | 1 |
| Masuda, T | 1 |
| Haji, S | 1 |
| Kimura, D | 1 |
| Nojiri, C | 1 |
| Nakashima, Y | 1 |
| Shiratsuchi, M | 1 |
| Kato, K | 1 |
| Miyamoto, T | 1 |
| Akashi, K | 1 |
| Nakashima, N | 1 |
| Ogawa, Y | 1 |
| Neguliaev, IuA | 1 |
| Vedernikova, EA | 1 |
| Maksimov, AV | 1 |
2 other studies available for aldosterone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.
Topics: Aldosterone; Angiotensins; Antihypertensive Agents; Enzyme Inhibitors; Glomerular Filtration Rate; H | 2022 |
[Aldosterone increases the activity level of Na+-conducting channels in chronic myeloid leukemia K562 cells].
Topics: Aldosterone; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Patch-Clamp Techniques; Sodiu | 1996 |